摘要
目的:通过对肝豆状核变性脑型患者的药学监护,探讨该病药学监护的方法和切入点。方法:通过参与1例肝豆状核变性脑型患者的全程药学监护,从驱铜治疗、对症治疗、24 h尿铜监测、患者饮食教育这几方面,探讨参与临床治疗方案的切入点。结果:临床药师应用循证医学的方法和临床医师共同制定驱铜治疗方案和药物剂量选择,开展忌铜饮食教育,提高患者的依从性,病情得到缓解。结论:临床药师与临床医师密切合作,参与临床药疗方案的制定,可进一步优化治疗方案,确保临床药物治疗的安全、有效、经济。
OBJECTIVE To explore pharmaceutial care and entry point for Wilson＇s disease combined with neurologic disease. METHODS Breakthrough points were investigated for clinical pharmacists to participate in clinical treatment. Pharmaceutical care for one patients with neurologic Wilson＇s disease was monitored during pharmaceutical therapy for removing copper, symptomatic treatment, 24-hour urine copper monitoring and patient education. RESULTS Evidence based medicine showed that, clinical pharmacists assisted clinicians making therapeutic plan for copper displacement and choosing doses, and developing patient education of copper diet. Eventually patient compliance was improved and the disease was relieved. CONCLUSlON Clinical pharmacists working together with clinicians by participating in clinical medical treatment can optimize therapeutic plan and ensure safety and efficacy of medication.
出处
《中国医院药学杂志》
CAS
CSCD
北大核心
2015年第19期1787-1790,共4页
Chinese Journal of Hospital Pharmacy
关键词
临床药师
药学监护
肝豆状核变性
clinical pharmaeist
pharmaceutical care
Wilson＇s disease
